Fig. 7

Cell viability of (a) Human liver (HepG2) cells and (b) Human Breast Cancer (MDA-MB-231) cell lines treated with different concentrations of biogenic FeNPs (from 0.5 to 16 µg/ml). Error bars represent standard deviation14.

Cell viability of (a) Human liver (HepG2) cells and (b) Human Breast Cancer (MDA-MB-231) cell lines treated with different concentrations of biogenic FeNPs (from 0.5 to 16 µg/ml). Error bars represent standard deviation14.